Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Graeme Griffin"'
Publikováno v:
Drug Discovery Today: Therapeutic Strategies. 1:397-401
Identifying the most optimal novel targets for cancer drug discovery is a challenge because of the multi-factorial nature of the disease. Carefully designed studies that probe protein function and give insight into biological roles enables sound choi
Autor:
Graeme Griffin, Anu Mahadevan, Raj K. Razdan, Mark C. Grier, Caroline E. Bass, Billy R. Martin
Publikováno v:
Pharmacology Biochemistry and Behavior. 74:31-40
The central cannabinoid receptor (CB1) antagonist, SR-141716A, has been used extensively to ascertain that cannabinoids interact with the CB1 receptor. SR-141716A has been shown to produce effects opposite of cannabinoids when administered alone. It
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 302:73-79
Fatty acid amides (FAAs) represent a class of neuromodulatory lipids that includes the endocannabinoid anandamide and the sleep-inducing substance oleamide. Both anandamide and oleamide produce behavioral effects indicative of cannabinoid activity, b
Autor:
Graeme Griffin, Ines Brandi, Mark C. Grier, William Williams, Raj K. Razdan, Sanjitha Kulasegram, Anu Mahadevan, Billy R. Martin, Vincenzo Di Marzo, Luciano De Petrocellis, Tiziana Bisogno
Publikováno v:
The Journal of pharmacology and experimental therapeutics
300 (2002): 984–991. doi:10.1124/jpet.300.3.984
info:cnr-pdr/source/autori:Di Marzo V., Griffin G., De Petrocellis L., Brandi I., Bisogno T., Williams W., Grier M.C., Kulasegram S., Mahadevan A., Razdan R.K., Martin B.R./titolo:A structure%2Factivity relationship study on arvanil, an endocannabinoid and vanilloid hybrid/doi:10.1124%2Fjpet.300.3.984/rivista:The Journal of pharmacology and experimental therapeutics (Print)/anno:2002/pagina_da:984/pagina_a:991/intervallo_pagine:984–991/volume:300
300 (2002): 984–991. doi:10.1124/jpet.300.3.984
info:cnr-pdr/source/autori:Di Marzo V., Griffin G., De Petrocellis L., Brandi I., Bisogno T., Williams W., Grier M.C., Kulasegram S., Mahadevan A., Razdan R.K., Martin B.R./titolo:A structure%2Factivity relationship study on arvanil, an endocannabinoid and vanilloid hybrid/doi:10.1124%2Fjpet.300.3.984/rivista:The Journal of pharmacology and experimental therapeutics (Print)/anno:2002/pagina_da:984/pagina_a:991/intervallo_pagine:984–991/volume:300
Arvanil, a structural "hybrid" between the endogenous cannabinoid CB1 receptor ligand anandamide and capsaicin, is a potent agonist for the capsaicin receptor VR1 (vanilloid receptor type 1), inhibits the anandamide membrane transporter (AMT), and in
Autor:
John W. Huffman, Renée G. Jefferson, Jenny L. Wiley, Graeme Griffin, John Liddle, Billy R. Martin, Shu Yu
Publikováno v:
Pharmacology. 66:89-99
The present study investigated the role of peripheral cannabinoid (CB2) receptors in producing hypomobility, antinociception and hypothermia in mice. Results revealed that the CB2-selective antagonist, SR144528, did not block cannabimimetic effects o
Publikováno v:
Molecular Pharmacology. 60:155-163
The purpose of these studies was to support the hypothesis that an undiscovered cannabinoid receptor exists in brain. [(35)S]GTP gamma S binding was stimulated by anandamide and WIN55212-2 in brain membranes from both CB(1)(+/+) and CB(1)(-/-) mice.
Autor:
Stephanie Williams, Mie Mie Aung, Graeme Griffin, Billy R. Martin, Raj K. Razdan, Mary E. Abood
Publikováno v:
British Journal of Pharmacology. 132:525-535
1. The activities of a number of side-chain analogues of delta-8-tetrahydrocannabinol (Delta(8)-THC) in rat cerebellar membrane preparations were tested. 2. The affinities of each compound for the CB(1) receptor were compared by their respective abil
Autor:
Bin Yang, Graeme Griffin, John W. Huffman, Mie Mie Aung, Vincent M. Showalter, Billy R. Martin, Mary E. Abood, Cheryl Keel, Ming-Jung Wu
Publikováno v:
Drug and Alcohol Dependence. 60:133-140
The N-1 alkyl side chain of the aminoalkylindole analogues (AAI) has been implicated as one of a three-point interaction with the cannabinoid CB(1) receptor. In this study, the morpholinoethyl of WIN 55,212-2 was replaced with carbon chains of varyin
Publikováno v:
British Journal of Pharmacology. 128:684-688
1. The effect of allosteric regulators on the binding affinity of a number of cannabinoid receptor ligands of varying efficacy in the rat cerebellum was investigated. 2. Radioligand ([3H]-SR141716A) competition curves were constructed in the presence
Autor:
Emma J Wray, Mary E. Abood, Raj K. Razdan, William K Rorrer, William R. Ryan, Peter J Crocker, Bijali Saha, Billy R. Martin, Graeme Griffin
Publikováno v:
British Journal of Pharmacology. 126:1575-1584
1. A number of side-chain analogues of delta8-THC were tested in GTPgammaS binding assay in rat cerebellar membranes. O-1125, a saturated side-chain compound stimulated GTPgammaS binding with an Emax of 165.0%, and an EC50 of 17.4 nM. 2. O-1236, O-12